BRD2 and ovarian hyperstimulation syndrome: The primary, independent risk factors associated with the development of OHSS in a gonadotropin-releasing hormone (GnRH)-antagonist protocol have recently been identified as low basal follicle-stimulating hormone (FSH), high peak estradiol (E2) after ovarian stimulation and a high number of growing follicles [3].